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The mission of National Institute of Environmental Health Sciences 
(NIEHS) is to improve the health of the American people by under-
standing the role of environmental exposures in disease and dysfunction. 
We accomplish this mission by conducting and funding research—
including in vitro, animal, and human studies—on the health effects of 
environmental agents. Our goal is to prevent disease by identifying and 
reducing exposures to environmental agents that compromise health. 
It is clear that every complex disease has both an environmental and 
a genetic component. Thus, NIEHS-sponsored research must play an 
important role in understanding disease etiology. In the last few years 
there have been workshops (Melnick et al. 2002; vom Saal et al. 2007), 
manuscripts (Myers et al. 2009a, 2009b), and even society-position 
papers (The Endocrine Society 2009) indicating that increased use 
of environmental health science data by policy makers should lead to 
reductions in the human burden of disease.
There are several recent examples of how research supported by the 
NIEHS is leading to paradigm shifts in understanding how environ-
mental toxicants—even at very low-level exposures—can have signifi-
cant consequences, including dysfunction and disease. These paradigm 
shifts are being informed by new approaches for dose measurement. 
NIEHS researchers are turning their attention to the “environmentally 
relevant dose,” which is the dose in the range of typical human exposure 
as measured in tissue, blood, and urine of study subjects. Simply put, 
the environmentally relevant dose is based on the internal concentration 
of the toxicant rather than the administered dose. 
In 2007, the NIEHS invited a panel of experts to Chapel Hill, 
North Carolina, for a scientific review of all literature published on 
bisphenol A (BPA). The expert panel then issued a consensus state-
ment (vom Saal et al. 2007), which concluded that low environmen-
tally relevant doses of BPA could cause numerous diseases in animal 
models, and that there was evidence for both low-dose effects and for 
non  monotonic dose–response relationships. Overall, similar conclu-
sions were reached by the National Toxicology Program’s Center for 
the Evaluation of Risks to Human Reproduction (NTP 2008), which 
focused on the developmental and reproductive effects of BPA. 
An article in this issue of Environmental Health Perspectives (Myers 
et al. 2009b) highlights this discussion of low-dose effects and notes 
that non  monotonic, or biphasic, dose–response curves are commonly 
observed in endocrinology. This suggests that high doses may not be 
appropriate to predict the safety of low doses when hormonally active 
or modulating compounds are studied. Their conclusions are supported 
by the position statement published by the Endocrine Society (2009). 
This debate—whether chemicals with endocrine-disrupting activity can 
cause toxicity at environ  mentally relevant doses—has been under way 
for more than a decade (Melnick et al. 2002). There are now low-dose 
data not only on BPA but also on phthalates, polychlorinated biphenyls 
(PCBs), dioxins, heavy metals such as lead and mercury, perchlorate, 
and some diverse pesticides such as hexachlorobenzene and atrazine. 
Indeed, the doses used in many animal toxicology studies result in 
internal concentrations that are in the range of human exposures. 
Many of these low-dose studies demonstrate that the timing of 
exposure is critical to the outcome and that exposures during early 
life stages (fetal, infant, and pubertal) are particularly important. This 
recog  nition of critical windows of vulnerability not only demonstrates 
the developmental basis of disease but also 
that the timing, as well as the dose, makes 
the poison.
Understanding the connection between 
our health and our environ  ment, with its 
mixture of chemicals, diet, and life  style stres-
sors, is no less complex than understanding the intricacies of the 
human genome; just as we have moved beyond “one gene, one dis-
ease,” we must move beyond “one chemical, one dose (range), one 
health outcome.” Reliability and validity are established in science by 
replication of findings in multiple independent studies. A weight-of- 
evidence approach is essential in understanding the public health 
impacts of environmental exposures. 
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